Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Malaria prevention follow-up study on neurobehavior and school outcomes in Kenyan children
ISRCTN12416717Phase 3Completed
- Sponsor
- KEMRI-Wellcome Trust Research Programme
- Start
- Sep 2019
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of RTS,S in Malaria (4 arms), sponsored by KEMRI-Wellcome Trust Research Programme. Primary endpoint: Prevalence of neurobehavioral impairments. Started Sep 2019; status: completed.
02
Drugs
RTS,S
03
Conditions
Malaria
Beyond the preview
Go deeper on ISRCTN12416717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN12416717.